PE20030098A1 - Capsulas elasticas blandas y composiciones de las mismas - Google Patents
Capsulas elasticas blandas y composiciones de las mismasInfo
- Publication number
- PE20030098A1 PE20030098A1 PE2002000436A PE2002000436A PE20030098A1 PE 20030098 A1 PE20030098 A1 PE 20030098A1 PE 2002000436 A PE2002000436 A PE 2002000436A PE 2002000436 A PE2002000436 A PE 2002000436A PE 20030098 A1 PE20030098 A1 PE 20030098A1
- Authority
- PE
- Peru
- Prior art keywords
- alcohol
- amino
- filler
- initial state
- agent
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US86628501A | 2001-05-25 | 2001-05-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20030098A1 true PE20030098A1 (es) | 2003-02-12 |
Family
ID=25347294
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2002000436A PE20030098A1 (es) | 2001-05-25 | 2002-05-24 | Capsulas elasticas blandas y composiciones de las mismas |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP1395249A1 (ja) |
JP (1) | JP2005508294A (ja) |
AR (1) | AR034995A1 (ja) |
CA (1) | CA2448438A1 (ja) |
MX (1) | MXPA03010771A (ja) |
PE (1) | PE20030098A1 (ja) |
UY (1) | UY27306A1 (ja) |
WO (1) | WO2002096395A1 (ja) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1175205B1 (en) | 1999-11-12 | 2006-06-14 | Abbott Laboratories | Solid dispersion comprising ritonavir, fenofibrate or griseofulvin |
US8025899B2 (en) | 2003-08-28 | 2011-09-27 | Abbott Laboratories | Solid pharmaceutical dosage form |
RU2014148964A (ru) | 2012-05-03 | 2016-06-27 | Сипла Лимитед | Антиретровирусная композиция |
WO2019130341A1 (en) * | 2017-12-26 | 2019-07-04 | Hetero Labs Limited | Capsule compositions comprising lopinavir and ritonavir |
GB201917252D0 (en) | 2019-11-27 | 2020-01-08 | Pharmaceutic compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6232333B1 (en) * | 1996-11-21 | 2001-05-15 | Abbott Laboratories | Pharmaceutical composition |
ZA9710071B (en) * | 1996-11-21 | 1998-05-25 | Abbott Lab | Pharmaceutical composition. |
MY145265A (en) * | 1998-07-20 | 2012-01-13 | Abbott Lab | Amorphous ritonavir |
ATE332132T1 (de) * | 1999-06-04 | 2006-07-15 | Abbott Lab | Verbesserte arzneizubereitungen enthaltend ritonavir |
US6608198B2 (en) * | 2000-03-30 | 2003-08-19 | Abbott Laboratories | Crystalline pharmaceutical |
-
2002
- 2002-05-21 WO PCT/US2002/015955 patent/WO2002096395A1/en active Application Filing
- 2002-05-21 MX MXPA03010771A patent/MXPA03010771A/es not_active Application Discontinuation
- 2002-05-21 CA CA002448438A patent/CA2448438A1/en not_active Abandoned
- 2002-05-21 JP JP2002592907A patent/JP2005508294A/ja active Pending
- 2002-05-21 EP EP02737019A patent/EP1395249A1/en not_active Withdrawn
- 2002-05-22 AR ARP020101897A patent/AR034995A1/es not_active Application Discontinuation
- 2002-05-24 PE PE2002000436A patent/PE20030098A1/es not_active Application Discontinuation
- 2002-05-24 UY UY27306A patent/UY27306A1/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR034995A1 (es) | 2004-04-14 |
MXPA03010771A (es) | 2004-07-01 |
JP2005508294A (ja) | 2005-03-31 |
CA2448438A1 (en) | 2002-12-05 |
EP1395249A1 (en) | 2004-03-10 |
UY27306A1 (es) | 2002-12-31 |
WO2002096395A1 (en) | 2002-12-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2008003491A1 (es) | Composicion farmaceutica en solucion que comprende ritonavir, un solvente organico que comprende un acido graso de cadena larga entre un 30-75% en peso total, agua entre 0,4-3,5% en peso total y opcionalmente un surfactante (divisional de la solicitud 1257-00). | |
PE20100363A1 (es) | Composiciones que comprenden nucleosidos | |
ES2191862T3 (es) | Composicion liquida que comprende un inhibidor de la vih proteasa y un acido graso de c12-c18. | |
BR0015605A (pt) | Composição e uso | |
AR037490A1 (es) | Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos | |
MXPA06008352A (es) | Una composicion farmaceutica. | |
AR024228A1 (es) | Una composicion farmaceutica que comprende un sensibilizador de insulina y otro agente antidiabetico | |
UY25055A1 (es) | Formulaciones farmacéuticas que contienen voriconazol | |
AR051340A1 (es) | Compuesto de c(4)- metoximetil acil pirrolidina, su uso para preparar un medicamento, formulacion farmaceutica que lo comprende y proceso para prepararlo | |
MX9202328A (es) | Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo. | |
AR027391A1 (es) | Composiciones farmaceuticas de toxina botulinica | |
ECSP045496A (es) | "preparaciones acidas de insulina con estabilidad mejorada" | |
AR049658A2 (es) | Ritonavir amorfo, su uso en la fabricacion de un medicamento, composicion farmaceutica, proceso para su preparacion y proceso para la preparacion de la forma polimorfa cristalina i de ritonavir. | |
BR0316310A (pt) | Composições farmacêuticas tendo um veìculo modificado | |
AR043863A1 (es) | Composiciones que contienen piperacilina y tazobactam, utiles para inyeccioines | |
AR006598A1 (es) | "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación" | |
NO306295B1 (no) | Heterosykliske forbindelser, farmasöytiske preparater som omfatter slike forbindelser, samt anvendelse av forbindelsene til fremstilling av medikamenter | |
DE602004015725D1 (de) | Stabilisierte lyophilisierte zubereitungen mit gewebefaktor-inhibitor (tfpi) oder varianten des gewebefaktor-inhibitors | |
KR940008681A (ko) | 디클로페낙 염용 비경구 용액 | |
ECSP034789A (es) | Composicion parenteral reconstituible que contiene un inhibidor cox-2 ta | |
BRPI0410488B8 (pt) | Composição farmacêutica líquida estabilizada e livre de hsa, método para preparação de composição farmacêutica líquida estabilizada e livre de hsa, e recipiente vedado hermeticamente | |
GEP20043285B (en) | Sustained Release Beadlets Containing Stavudine, Method for Their Production, Pharmaceutical Composition Containing the Same and Use Thereof for Treatment Retroviral Infections | |
PE20030098A1 (es) | Capsulas elasticas blandas y composiciones de las mismas | |
BR0208727A (pt) | Eritropoietina melhorando a toxicidade in vivo induzida por quimioterapia | |
BRPI0418070A (pt) | composição para cuidados pessoais, uso de uma uréia substituìda e método para reduzir a degradação da cor de uma composição para cuidados pessoais |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC | Refusal |